| |
|
|
|
Hemispherx Biopharma Inc.  
|
|
0.229 -0.001 (-0%) |
02-19 15:44 |
|
Open: |
0.23 |
Pre close: |
0.23 |
Target:
|
0.29
|
|
High: |
0.2318 |
Low: |
0.2236 |
Resistance:
|
0.25
0.27
|
|
Volume: |
170,505 |
Market Cap: |
11M |
Support:
|
0.21
0.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.24
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
0.23  |
Signal(12,26,9): |
0.01 |
|
MA(100): |
0.22 |
Stochastic Oscillator |
%K(14,3):
|
26.00 |
|
MA(250): |
0.29 |
%D(3): |
42.00 |
|
Average Volume(K) |
3-Month: |
28235
|
52-Week |
High:
|
0.59 |
|
10-Days: |
27392 |
Low: |
0.15 |
|
RSI |
RSI(14):
|
49.81 |
Change(%): |
-48.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-124.3 |
Shares Out. (M) |
48.19 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-68.5 |
Shares Float (M) |
44.36 |
|
EPS Est. Next Year |
-0.030 |
PEG Ratio |
-0.04 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-57.8 |
% Held by Institutions |
5.50 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
624 |
|
Book Value (p.s.) |
1.870 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.12 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.98 |
P/S |
0.00 |
|
Operating Margin |
-6565.54 |
Levered Free Cash Flow
(M) |
-5.66 |
P/CF |
-1.23 |
|
|
|
|
|
|
